Richard Boucher
Director
Credentials: · ·
History
Columbia Presbyterian Hospital
- 1970
Columbia College of Physicians and Surgeons
Research
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Cell · 2020 · 1,251 citations
Journal of Clinical Investigation · 2002 · 967 citations
Mucus clearance as a primary innate defense mechanism for mammalian airways
Review · Journal of Clinical Investigation · 2002 · 895 citations
68 papers
- JY
38 papers
24 papers
22 papers · 1 as a fellow
19 papers
15 papers
15 papers
12 papers · 4 as a resident
Grants
- 2003–2030
UNC Cystic Fibrosis Research and Translation Core Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Contact PI · $25.3M · Univ of North Carolina Chapel Hill
- 2025–2030
Rare Bronchiectatic Diseases Consortium
National Heart, Lung, and Blood Institute · U54
PI · $2.9M · Univ of North Carolina Chapel Hill
- 2026–2030
National Heart, Lung, and Blood Institute · R01
PI · $777.5K · Univ of North Carolina Chapel Hill
- 2026–2030
A Unifying Muco-Obstructive Paradigm for Bronchiectasis
National Heart, Lung, and Blood Institute · R01
PI · $777.4K · Univ of North Carolina Chapel Hill
Clinical trials
- 2006–2012
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2017
Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
Study chair · Completed
University of North Carolina, Chapel Hill